ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

In Brief: John Mendelson To Succeed LaMaistre As President, M.D Anderson Cancer Center

May 17, 1996

ACS Cancer Control Research Grant Programs Available

May 5, 2000

Hatch Introduces Bill to Modify Delaney Amendment

June 13, 1986

Alternative Medicine Officer Awards 30 Research Grants

October 15, 1993

Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers

January 29, 1993